Cardioneuroablation for vasovagal syncope: insights on patients’ selection, centre settings, procedural workflow and endpoints—results from an European Heart Rhythm Association survey
Diego Penela(Hospital Quirón Teknon), K. R. Julian Chun(Agaplesion Bethanien Krankenhaus), Giulio Falasconi(Hospital Quirón Teknon), Piotr Futyma(University of Rzeszów), Rui Providência(Rutgers, The State University of New Jersey), Laurent Roten(University of Bern), Antonio Berruezo(Hospital Quirón Teknon), Sergio Richter(Leipzig Heart Institute)
Cited by 17
Related Papers
Tailored Atrial Substrate Modification Based on Low-Voltage Areas in Catheter Ablation of Atrial Fibrillation
|Circulation Arrhythmia and Electrophysiology|2014|561
Individually tailored vs. standardized substrate modification during radiofrequency catheter ablation for atrial fibrillation: a randomized study
|EP Europace|2017|197
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia
|Journal of the American College of Cardiology|2022|175
Comparison of CHADS <sub>2</sub> , R <sub>2</sub> CHADS <sub>2</sub> , and CHA <sub>2</sub> DS <sub>2</sub> -VASc Scores for the Prediction of Rhythm Outcomes After Catheter Ablation of Atrial Fibrillation
|Circulation Arrhythmia and Electrophysiology|2014|110
Quality indicators for the care and outcomes of adults with atrial fibrillation
|EP Europace|2020|98